ReP USP - Resultado da busca

Monografia/livro-ed/org
Chimeric antigen receptor T Cells: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, BIOLOGIA MOLECULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cells: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024. , 2020
APA
Chimeric antigen receptor T Cells: development and production. (2020). Chimeric antigen receptor T Cells: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Monografia/livro-ed/org
Chimeric antigen receptor T Cell: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, LINHAGEM CELULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cell: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024. , 2020
APA
Chimeric antigen receptor T Cell: development and production. (2020). Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro-apres/pref/posf
Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] (2020)
Swiech, Kamilla ; Malmegrim, Kelen Cristina Ribeiro ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, RECEPTORES DE ANTÍGENOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWIECH, Kamilla e MALMEGRIM, Kelen Cristina Ribeiro e PICANÇO-CASTRO, Virgínia. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024. , 2020
APA
Swiech, K., Malmegrim, K. C. R., & Picanço-Castro, V. (2020). Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Artigo de periodico
Emerging patent landscape for non-viral vectors used for gene therapy (2020)
Picanço-Castro, Virgínia; Pereira, Cristiano Gonçalves; Covas, Dimas Tadeu; Porto, Geciane Silveira ; Athanassiadou, Aglaia; Figueiredo, Marxa Leão
Source: Nature Biotechnology. Unidades: FMRP, FEARP
Subjects: GENÉTICA APLICADA, REGULAÇÃO GÊNICA, DNA RECOMBINANTE, PATENTE, PUBLICAÇÕES ACADÊMICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging patent landscape for non-viral vectors used for gene therapy. Nature Biotechnology, v. 38, n. 2, p. 151–158, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41587-019-0402-x. Acesso em: 14 nov. 2024.
APA
Picanço-Castro, V., Pereira, C. G., Covas, D. T., Porto, G. S., Athanassiadou, A., & Figueiredo, M. L. (2020). Emerging patent landscape for non-viral vectors used for gene therapy. Nature Biotechnology, 38( 2), 151–158. doi:10.1038/s41587-019-0402-x
NLM
Picanço-Castro V, Pereira CG, Covas DT, Porto GS, Athanassiadou A, Figueiredo ML. Emerging patent landscape for non-viral vectors used for gene therapy [Internet]. Nature Biotechnology. 2020 ; 38( 2): 151–158.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41587-019-0402-x
Vancouver
Picanço-Castro V, Pereira CG, Covas DT, Porto GS, Athanassiadou A, Figueiredo ML. Emerging patent landscape for non-viral vectors used for gene therapy [Internet]. Nature Biotechnology. 2020 ; 38( 2): 151–158.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41587-019-0402-x
Trabalho de evento-resumo periodico
Non-viral engineering of CAR-NK cells for cancer immunotherapy (2020)
Gomes, Kauan Ribeiro de Sena; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LINFÓCITOS, CÉLULAS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Kauan Ribeiro de Sena et al. Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.706. Acesso em: 14 nov. 2024. , 2020
APA
Gomes, K. R. de S., Silvestre, R. N., Azevedo, J. T. C. de, Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.706
NLM
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Vancouver
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Trabalho de evento-resumo periodico
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
Silvestre, Renata Nacasaki; Eitler, J.; Fantacini, Daianne Maciely Carvalho ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu; Tonn, T.; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 14 nov. 2024. , 2020
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Trabalho de evento-resumo periodico
Optimizing intracellular signaling domains for CAR-NK cells (2020)
Azevedo, Júlia Teixeira Cottas de; Silvestre, Renata Nacasaki; Pessoni, André Moreira ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, NEOPLASIAS, PROLIFERAÇÃO CELULAR, LEUCEMIA, LINFOMA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.710. Acesso em: 14 nov. 2024. , 2020
APA
Azevedo, J. T. C. de, Silvestre, R. N., Pessoni, A. M., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.710
NLM
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Vancouver
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Parte de monografia/livro
Determination of cytotoxic potential of CAR-T cells in co-cultivation assays (2020)
Silvestre, Renata Nacasaki ; Moço, Pablo Diego ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidade: FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, NEOPLASIAS, LINHAGEM CELULAR, CITOTOXICIDADE IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki e MOÇO, Pablo Diego e PICANÇO-CASTRO, Virgínia. Determination of cytotoxic potential of CAR-T cells in co-cultivation assays. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024.
APA
Silvestre, R. N., Moço, P. D., & Picanço-Castro, V. (2020). Determination of cytotoxic potential of CAR-T cells in co-cultivation assays. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Silvestre RN, Moço PD, Picanço-Castro V. Determination of cytotoxic potential of CAR-T cells in co-cultivation assays [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Silvestre RN, Moço PD, Picanço-Castro V. Determination of cytotoxic potential of CAR-T cells in co-cultivation assays [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Artigo de periodico
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies (2020)
Picanço-Castro, Virgínia; Moço, Pablo Diego; Mizukami, Amanda; Vaz, Leticia Delfini; Pereira, Marcelo de Souza Fernandes; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Bomfim, Aline de Sousa; Abreu-Neto, Mário Soares de; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu
Source: Hematology, Transfusion and Cell Therapy. Unidades: FCFRP, FMRP
Subjects: HEMATOLOGIA, CITOTOXICIDADE IMUNOLÓGICA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, v. 42, n. 2, p. 150-158, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.06.007. Acesso em: 14 nov. 2024.
APA
Picanço-Castro, V., Moço, P. D., Mizukami, A., Vaz, L. D., Pereira, M. de S. F., Silvestre, R. N., et al. (2020). Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, 42( 2), 150-158. doi:10.1016/j.htct.2019.06.007
NLM
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Vancouver
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Parte de monografia/livro
Generation of tumor cells expressing Firefly Luciferase (fLuc) to evaluate the effectiveness of CAR in a murine model (2020)
Pereira, Marcelo de Souza Fernandes; Fantacini, Daianne Maciely Carvalho ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidade: FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, NEOPLASIAS, BIOLUMINESCÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marcelo de Souza Fernandes e FANTACINI, Daianne Maciely Carvalho e PICANÇO-CASTRO, Virgínia. Generation of tumor cells expressing Firefly Luciferase (fLuc) to evaluate the effectiveness of CAR in a murine model. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024.
APA
Pereira, M. de S. F., Fantacini, D. M. C., & Picanço-Castro, V. (2020). Generation of tumor cells expressing Firefly Luciferase (fLuc) to evaluate the effectiveness of CAR in a murine model. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Pereira M de SF, Fantacini DMC, Picanço-Castro V. Generation of tumor cells expressing Firefly Luciferase (fLuc) to evaluate the effectiveness of CAR in a murine model [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Pereira M de SF, Fantacini DMC, Picanço-Castro V. Generation of tumor cells expressing Firefly Luciferase (fLuc) to evaluate the effectiveness of CAR in a murine model [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro
Optimized production of lentiviral vectors for CAR-T Cell (2020)
Moço, Pablo Diego ; Abreu-Neto, Mário Soares de; Fantacini, Daianne Maciely Carvalho ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidade: FMRP
Subjects: LENTIVIRUS, RECEPTORES DE ANTÍGENOS, TRANSFERÊNCIA DE GENES, ANTÍGENOS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOÇO, Pablo Diego et al. Optimized production of lentiviral vectors for CAR-T Cell. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 14 nov. 2024.
APA
Moço, P. D., Abreu-Neto, M. S. de, Fantacini, D. M. C., & Picanço-Castro, V. (2020). Optimized production of lentiviral vectors for CAR-T Cell. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Moço PD, Abreu-Neto MS de, Fantacini DMC, Picanço-Castro V. Optimized production of lentiviral vectors for CAR-T Cell [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Moço PD, Abreu-Neto MS de, Fantacini DMC, Picanço-Castro V. Optimized production of lentiviral vectors for CAR-T Cell [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro
CAR-T cells for cancer treatment: current design and next frontiers (2020)
Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu
Source: Chimeric Antigen Receptor T Cell: Development and Production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, NEOPLASIAS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. CAR-T cells for cancer treatment: current design and next frontiers. Chimeric Antigen Receptor T Cell: Development and Production. Tradução . New York: Humana Press, 2020. . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4_1. Acesso em: 14 nov. 2024.
APA
Picanço-Castro, V., Swiech, K., Farias, K. C. R. M. de, & Covas, D. T. (2020). CAR-T cells for cancer treatment: current design and next frontiers. In Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4_1
NLM
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1
Vancouver
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1
Artigo de periodico
Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin (2020)
Silva, Luciano Costa e; Santos, Matheus Henrique; Heluy, Tárik Reis; Biaggio, Rafael Tagé; Ferreira, Alexander Rodrigo ; Lima, Jonathan Milhomens dos Santos; Haddad, Simone Kashima ; El Nemer, Wassim; El Hoss, Sara; Picanço-Castro, Virgínia ; Covas, Dimas Tadeu ; Swiech, Kamilla
Source: Engineering Reports. Unidades: FMRP, FCFRP
Subjects: ERITROPOIETINA, GLICOPROTEÍNAS, PROTEÍNAS RECOMBINANTES, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Luciano Costa e et al. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin. Engineering Reports, v. 2, n. 6, p. 1-16, 2020Tradução . . Disponível em: https://doi.org/10.1002/eng2.12172. Acesso em: 14 nov. 2024.
APA
Silva, L. C. e, Santos, M. H., Heluy, T. R., Biaggio, R. T., Ferreira, A. R., Lima, J. M. dos S., et al. (2020). Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin. Engineering Reports, 2( 6), 1-16. doi:10.1002/eng2.12172
NLM
Silva LC e, Santos MH, Heluy TR, Biaggio RT, Ferreira AR, Lima JM dos S, Haddad SK, El Nemer W, El Hoss S, Picanço-Castro V, Covas DT, Swiech K. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin [Internet]. Engineering Reports. 2020 ; 2( 6): 1-16.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/eng2.12172
Vancouver
Silva LC e, Santos MH, Heluy TR, Biaggio RT, Ferreira AR, Lima JM dos S, Haddad SK, El Nemer W, El Hoss S, Picanço-Castro V, Covas DT, Swiech K. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin [Internet]. Engineering Reports. 2020 ; 2( 6): 1-16.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/eng2.12172
Artigo de periodico
Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
Picanço-Castro, Virgínia; Pereira, Cristiano Gonçalves; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Porto, Geciane Silveira
Source: Human Vaccines & Immunotherapeutics. Unidades: FMRP, FCFRP, FEARP
Subjects: PATENTE, TECNOLOGIA, CÉLULAS, TESTES LABORATORIAIS, INOVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 14 nov. 2024.
APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744
NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/21645515.2019.1689744

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration